Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pharma Tech Trends and Development Cost Solutions

Published: Thursday, April 04, 2013
Last Updated: Thursday, April 04, 2013
Bookmark and Share
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.

The free webinar lays out the pressures currently being faced by the industry—including cost and regulatory pressures—and explores the chemistry workflows and emerging technologies that are helping industry participants address these challenges, remain competitive, and protect profits.

With the reality of patent cliffs, regulatory standards, attrition, and globalization, companies are learning to work fast and “lean” without sacrificing effectiveness and safety. In the webinar, targeted technology application and the methodologies it enables results in an ability to handle increased experiment volume—the kind that will be required for success if pharmaceutical industry trends continue—while lowering development and production costs.

Accounting for issues such as inherited chemistry, variable yields, and long development cycles, the webinar looks at real-world examples of industry giants such as Pfizer using technologies that help understand particle and reaction characteristics for significant process enhancement. In situ mid-IR spectroscopy and Focus Beam Reflectance Measurement (FBRM®)—as well as workstations that incorporate them—are shown to illuminate particle growth/crystallization and other critical reaction characteristics to shorten cycle times, increase yields, enhance safety, and ease scale-up. One production initiation example lowered costs by at least $.5M—a savings that will compound with each successive use of the equipment.

Reaction Progress Kinetics Analysis is also discussed in detail. This methodology, developed by Professor Donna Blackmond who is currently with Scripps Research Institute, allowed researchers to develop a kinetic model in significantly fewer experiments over traditional methods, which in turn helped optimize a synthetic route for enhanced commercial viability.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

METTLER TOLEDO Announces a New Symposium on Process Chemistry and Scale-Up
Company has announced that the discover methods entitled Process Chemistry and Scale-up Online Seminar featuring R&D scientists from Air Products and Nalas Engineering.
Wednesday, March 16, 2016
The Art of Pipetting
Sculptor and installation artist Mitra Fabian has created an iceberg sculpture made from recycled pipette tips.
Friday, February 05, 2016
13 Ways to Stop an Unseen Force from Disrupting Weighing
Download a free Mettler Toledo paper to discover how to halt static’s negative effects before the next weigh-in.
Saturday, October 03, 2015
Lab Scale Manufacturing Using Continuous Crystallization
A new METTLER TOLEDO On-demand webinar explores recent research that could revolutionize pharmaceutical production.
Tuesday, April 15, 2014
Mettler-Toledo Awarded Foreign Designated Manufacturer Certification
Mettler Toledo is the first balance manufacturer to win FDM certification in Japan.
Friday, July 26, 2013
Free Webinar Explores Safe Scaling of Pressure Reactions
Robust in situ technology allows cost effective scale-up pressure reactions.
Friday, May 24, 2013
Mettler-Toledo and Konica Minolta Join Forces
Strategic partnership in the field of multi-parameter analysis for the Flavours & Fragrances industry.
Friday, May 18, 2012
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Mechanism of Tuberculosis Infection
Researchers at UTSW Medical Center have identified a new way that tuberculosis bacteria get into the body, revealing a potential therapeutic angle to explore.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Eliminating Doubt in Criminal Investigations
New ASU certificate to help curb error, misunderstanding in the quest for justice.
Determination of 13 Organic Toxicants in Human Blood
Researchers have utilised liquid-liquid extraction coupling HPLC-MS/MS to identify and quantify organic toxicants in human blood.
A Novel Cell Culture Model For Forensic Biology Experiments
Researchers have developed a new cell culture model which provides an efficient research tool in forensic biology.
Rhino DNA Bank Aids Anti-Poaching Fight
At the University of Pretoria's Veterinary Genetics Laboratory (VGL) at Onderstepoort, Dr Cindy Harper and her team have developed a ground-breaking technique to collect and catalogue DNA from rhinos and rhino horns.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!